Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...

The study, published earlier this year in the Proceedings of the National Academy of Sciences, examined how abnormal cells ...

A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug ...

For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often ...

Jay Harris, who has anchored for SportsCenter for over 10 years has shared he has been diagnosed with prostate cancer and ...

Routine ultrasonography may trigger needless biopsies and hysteroscopies, say experts on quaternary prevention in cancer care ...

This week’s loving giving local donation goes to an organization that helps women and men in the fight against cancer. It all started with Paula’s story and now it’s ...

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

Danielle Campfield-Carter will celebrate two years cancer free, but her journey to remission has been anything but easy.

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endome | Genmab has shared the first data on ...

Investing.com -- Genmab (NASDAQ: GMAB) has unveiled new data for its cancer drug Rina-S, which is being tested for use in endometrial cancer. This follows promising early results from trials in ...

Teddi Mellencamp confirmed she’s in a new relationship amid her journey with cancer. Despite the public attention they’ve ...